terrible results. NPAT down 8%, did a lot of acquisitions, debt increasing. page reference 8 for NPAT $7.6Mthis is a low quality business and priced so.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game